G. Kijak and F. Mccutchan, HIV diversity, molecular epidemiology, and the role of recombination, Current Infectious Disease Reports, vol.21, issue.Suppl 3, pp.480-488, 2005.
DOI : 10.1097/00126334-200204010-00015

B. Korber, B. Gaschen, K. Yusim, R. Thakallapally, C. Kesmir et al., Evolutionary and immunological implications of contemporary HIV-1 variation, British Medical Bulletin, vol.58, issue.1, pp.19-42, 2001.
DOI : 10.1093/bmb/58.1.19

K. Nolan, A. Jordan, and J. Hoxie, Effects of Partial Deletions within the Human Immunodeficiency Virus Type 1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors, Journal of Virology, vol.82, issue.2, pp.664-73, 2008.
DOI : 10.1128/JVI.01793-07

M. Laakso, F. Lee, B. Haggarty, C. Agrawal, K. Nolan et al., V3 Loop Truncations in HIV-1 Envelope Impart Resistance to Coreceptor Inhibitors and Enhanced Sensitivity to Neutralizing Antibodies, PLoS Pathogens, vol.68, issue.8, p.117, 2007.
DOI : 1098-5514(1994)068[5509:BMASAO]2.0.CO;2

M. Kowalski, J. Potz, L. Basiripour, T. Dorfman, W. Goh et al., Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1, Science, vol.237, issue.4820, pp.1351-1356, 1987.
DOI : 10.1126/science.3629244

C. Krachmarov, S. Kayman, W. Honnen, O. Trochev, and A. Pinter, V3-Specific Polyclonal Antibodies Affinity Purified from Sera of Infected Humans Effectively Neutralize Primary Isolates of Human Immunodeficiency Virus Type 1, AIDS Research and Human Retroviruses, vol.17, issue.18, pp.1737-1785, 2001.
DOI : 10.1089/08892220152741432

M. Gorny, K. Revesz, C. Williams, B. Volsky, M. Louder et al., The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope, Journal of Virology, vol.78, issue.5, pp.2394-404, 2004.
DOI : 10.1128/JVI.78.5.2394-2404.2004

M. Gorny, J. Xu, S. Karwowska, A. Buchbinder, and S. Zolla-pazner, Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120, J Immunol, vol.150, issue.2, pp.635-678, 1993.

A. Ly and L. Stamatatos, V2 Loop Glycosylation of the Human Immunodeficiency Virus Type 1 SF162 Envelope Facilitates Interaction of This Protein with CD4 and CCR5 Receptors and Protects the Virus from Neutralization by Anti-V3 Loop and Anti-CD4 Binding Site Antibodies, Journal of Virology, vol.74, issue.15, pp.6769-76, 2000.
DOI : 10.1128/JVI.74.15.6769-6776.2000

R. Ogert, M. Lee, W. Ross, A. Buckler-white, M. Martin et al., N-Linked Glycosylation Sites Adjacent to and within the V1/V2 and the V3 Loops of Dualtropic Human Immunodeficiency Virus Type 1 Isolate DH12 gp120 Affect Coreceptor Usage and Cellular Tropism, Journal of Virology, vol.75, issue.13, pp.5998-6006, 2001.
DOI : 10.1128/JVI.75.13.5998-6006.2001

G. Pollakis, S. Kang, A. Kliphuis, M. Chalaby, J. Goudsmit et al., Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization, Journal of Biological Chemistry, vol.69, issue.16, pp.13433-13474, 2001.
DOI : 10.1089/aid.1994.10.1387

T. Shioda, S. Oka, X. Xin, H. Liu, R. Harukuni et al., In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression, J Virol, vol.71, pp.4871-81, 1997.

L. Stamatatos and C. Cheng-mayer, An envelope modification that renders a primary , neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades, J Virol, vol.72, pp.7840-7845, 1998.

K. Toohey, K. Wehrly, J. Nishio, S. Perryman, and B. Chesebro, Human Immunodeficiency Virus Envelope V1 and V2 Regions Influence Replication Efficiency in Macrophages by Affecting Virus Spread, Virology, vol.213, issue.1, pp.70-79, 1995.
DOI : 10.1006/viro.1995.1547

B. Walter, K. Wehrly, R. Swanstrom, E. Platt, D. Kabat et al., Role of Low CD4 Levels in the Influence of Human Immunodeficiency Virus Type 1 Envelope V1 and V2 Regions on Entry and Spread in Macrophages, Journal of Virology, vol.79, issue.8, pp.4828-4865, 2005.
DOI : 10.1128/JVI.79.8.4828-4837.2005

K. Ritola, C. Pilcher, S. Fiscus, N. Hoffman, J. Nelson et al., Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1, Journal of Virology, vol.78, issue.20, pp.11208-11226, 1920.
DOI : 10.1128/JVI.78.20.11208-11218.2004
URL : http://jvi.asm.org/content/78/20/11208.full.pdf

C. Derdeyn, J. Decker, F. Bibollet-ruche, J. Mokili, M. Muldoon et al., Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission, Science, vol.303, issue.5666, pp.2019-2041, 2004.
DOI : 10.1126/science.1093137

B. Chohan, D. Lang, M. Sagar, B. Korber, L. Lavreys et al., Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels, Journal of Virology, vol.79, issue.10, pp.6528-6559, 2005.
DOI : 10.1128/JVI.79.10.6528-6531.2005

M. Sagar, X. Wu, S. Lee, and J. Overbaugh, Human Immunodeficiency Virus Type 1 V1-V2 Envelope Loop Sequences Expand and Add Glycosylation Sites over the Course of Infection, and These Modifications Affect Antibody Neutralization Sensitivity, Journal of Virology, vol.80, issue.19, pp.9586-98, 2006.
DOI : 10.1128/JVI.00141-06

K. Kitrinos, N. Hoffman, J. Nelson, and R. Swanstrom, Turnover of env Variable Region 1 and 2 Genotypes in Subjects with Late-Stage Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.77, issue.12, pp.6811-6833, 2003.
DOI : 10.1128/JVI.77.12.6811-6822.2003

J. Cao, N. Sullivan, E. Desjardin, C. Parolin, J. Robinson et al., Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein, J Virol, vol.71, pp.9808-9820, 1997.

C. Cheng-mayer, A. Brown, J. Harouse, P. Luciw, and A. Mayer, Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation, J Virol, vol.73, pp.5294-300, 1999.

W. Johnson, J. Morgan, J. Reitter, B. Puffer, S. Czajak et al., A Replication-Competent, Neutralization-Sensitive Variant of Simian Immunodeficiency Virus Lacking 100 Amino Acids of Envelope, Journal of Virology, vol.76, issue.5, pp.2075-86, 2002.
DOI : 10.1128/jvi.76.5.2075-2086.2002

J. Reitter, R. Means, and R. Desrosiers, A role for carbohydrates in immune evasion in AIDS, Nature Medicine, vol.68, issue.6, pp.679-84, 1998.
DOI : 10.1073/pnas.94.19.10018

L. Rudensey, J. Kimata, E. Long, B. Chackerian, and J. Overbaugh, Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication , cytopathicity, or CCR-5 coreceptor recognition, J Virol, vol.72, issue.1, pp.209-226, 1998.

W. Blay, S. Gnanakaran, B. Foley, N. Doria-rose, B. Korber et al., Consistent Patterns of Change during the Divergence of Human Immunodeficiency Virus Type 1 Envelope from That of the Inoculated Virus in Simian/Human Immunodeficiency Virus-Infected Macaques, Journal of Virology, vol.80, issue.2, pp.999-1014, 2006.
DOI : 10.1128/JVI.80.2.999-1014.2006

B. Chackerian, L. Rudensey, and J. Overbaugh, Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies, J Virol, vol.71, pp.7719-7746, 1997.

T. Wolk and M. Schreiber, N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization, Medical Microbiology and Immunology, vol.51, issue.3, pp.165-72, 2003.
DOI : 10.1007/s00430-006-0016-z

D. Benko, S. Schwartz, G. Pavlakis, and B. Felber, A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins, J Virol, vol.64, issue.6, pp.2505-2523, 1990.

J. Salfeld, H. Gottlinger, R. Sia, R. Park, J. Sodroski et al., A tripartite HIV-1 tat-env-rev fusion protein, EMBO J, vol.9, pp.965-70, 1990.

M. Furtado, R. Balachandran, P. Gupta, and S. Wolinsky, Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel TAT-ENV fusion protein, Virology, vol.185, issue.1, pp.258-70, 1991.
DOI : 10.1016/0042-6822(91)90773-5

J. Hartikka, M. Sawdey, F. Cornefert-jensen, M. Margalith, K. Barnhart et al., An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal Muscle, Human Gene Therapy, vol.7, issue.10, pp.1205-1222, 1996.
DOI : 10.1089/hum.1996.7.10-1205

M. Rosati, A. Von-gegerfelt, P. Roth, C. Alicea, A. Valentin et al., DNA Vaccines Expressing Different Forms of Simian Immunodeficiency Virus Antigens Decrease Viremia upon SIVmac251 Challenge, Journal of Virology, vol.79, issue.13, pp.8480-92, 2005.
DOI : 10.1128/JVI.79.13.8480-8492.2005

V. Gómez-román, L. Patterson, D. Venzon, D. Liewehr, K. Aldrich et al., Vaccine-Elicited Antibodies Mediate Antibody-Dependent Cellular Cytotoxicity Correlated with Significantly Reduced Acute Viremia in Rhesus Macaques Challenged with SIVmac251, The Journal of Immunology, vol.174, issue.4, pp.2185-2194, 2005.
DOI : 10.4049/jimmunol.174.4.2185

V. Gómez-román, R. Florese, L. Patterson, B. Peng, D. Venzon et al., A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity, Journal of Immunological Methods, vol.308, issue.1-2, pp.53-67, 2006.
DOI : 10.1016/j.jim.2005.09.018

D. Forthal and G. Landucci, In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity, Journal of Immunological Methods, vol.220, issue.1-2, pp.129-167, 1998.
DOI : 10.1016/S0022-1759(98)00152-5

G. Karlsson, M. Halloran, J. Li, I. Park, R. Gomila et al., Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys, J Virol, vol.71, issue.6, pp.4218-4243, 1997.

D. Montefiori, Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays, Curr Protoc Immunol, vol.280, 2005.
DOI : 10.1002/0471142735.im1211s64

M. Li, F. Gao, J. Mascola, L. Stamatatos, V. Polonis et al., Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies, Journal of Virology, vol.79, issue.16, pp.10108-10133, 2005.
DOI : 10.1128/JVI.79.16.10108-10125.2005

N. Haigwood, D. Montefiori, W. Sutton, J. Mcclure, A. Watson et al., Passive Immunotherapy in Simian Immunodeficiency Virus-Infected Macaques Accelerates the Development of Neutralizing Antibodies, Journal of Virology, vol.78, issue.11, pp.5983-95, 2004.
DOI : 10.1128/JVI.78.11.5983-5995.2004

X. Liang, D. Casimiro, W. Schleif, F. Wang, M. Davies et al., Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A*01-Negative Rhesus Monkeys, Journal of Virology, vol.79, issue.19, pp.12321-12352, 2005.
DOI : 10.1128/JVI.79.19.12321-12331.2005
URL : http://jvi.asm.org/content/79/19/12321.full.pdf

P. Silvera, M. Richardson, J. Greenhouse, J. Yalley-ogunro, N. Shaw et al., Outcome of Simian-Human Immunodeficiency Virus Strain 89.6p Challenge following Vaccination of Rhesus Macaques with Human Immunodeficiency Virus Tat Protein, Journal of Virology, vol.76, issue.8, pp.3800-3809, 2002.
DOI : 10.1128/JVI.76.8.3800-3809.2002

J. Moore, L. Wallace, E. Follett, and J. Mckeating, An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1, Aids, vol.3, issue.3, pp.155-63, 1989.
DOI : 10.1097/00002030-198903000-00006

Y. Wang, X. Han, M. An, D. Dai, B. Zhao et al., Coreceptor usage of human immunodeficiency virus-1 in primary infection through sexual contact transmission, Zhonghua Yi Xue Za Zhi, vol.91, pp.1457-62, 2011.

C. Cicala, J. Arthos, and A. Fauci, HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV, Journal of Translational Medicine, vol.9, issue.Suppl 1, p.2, 2011.
DOI : 10.1186/1479-5876-9-S1-S2

T. Demberg, R. Florese, M. Heath, K. Larsen, I. Kalisz et al., A Replication-Competent Adenovirus-Human Immunodeficiency Virus (Ad-HIV) tat and Ad-HIV env Priming/Tat and Envelope Protein Boosting Regimen Elicits Enhanced Protective Efficacy against Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques, Journal of Virology, vol.81, issue.7, pp.3414-3441, 2007.
DOI : 10.1128/JVI.02453-06
URL : http://jvi.asm.org/content/81/7/3414.full.pdf

P. Kolchinsky, E. Kiprilov, and J. Sodroski, Increased Neutralization Sensitivity of CD4-Independent Human Immunodeficiency Virus Variants, Journal of Virology, vol.75, issue.5, pp.2041-50, 2001.
DOI : 10.1128/JVI.75.5.2041-2050.2001

T. Matano, R. Shibata, C. Siemon, M. Connors, H. Lane et al., Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques, J Virol, vol.72, issue.1, pp.164-173, 1998.

J. Schmitz, R. Johnson, H. Mcclure, K. Manson, M. Wyand et al., Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239??3-Vaccinated Rhesus Macaques, Journal of Virology, vol.79, issue.13, pp.8131-8172, 2005.
DOI : 10.1128/JVI.79.13.8131-8141.2005

M. Vaccari, J. Mattapallil, K. Song, W. Tsai, A. Hryniewicz et al., Reduced Protection from Simian Immunodeficiency Virus SIVmac251 Infection Afforded by Memory CD8+ T Cells Induced by Vaccination during CD4+ T-Cell Deficiency, Journal of Virology, vol.82, issue.19, pp.9629-9667, 2008.
DOI : 10.1128/JVI.00893-08
URL : http://jvi.asm.org/content/82/19/9629.full.pdf

R. Amara, F. Villinger, J. Altman, S. Lydy, O. Neil et al., Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine, Science, vol.292, issue.5514, pp.69-74, 2001.
DOI : 10.1126/science.1058915

N. Malkevitch, D. Rohne, J. Pinczewski, K. Aldrich, V. Kalyanaraman et al., Evaluation of Combination DNA/Replication-Competent Ad-SIV Recombinant Immunization Regimens in Rhesus Macaques, AIDS Research and Human Retroviruses, vol.20, issue.2, pp.235-279, 2004.
DOI : 10.1089/088922204773004969

L. Patterson, N. Malkevitch, D. Venzon, J. Pinczewski, V. Gómez-román et al., Protection against Mucosal Simian Immunodeficiency Virus SIVmac251 Challenge by Using Replicating Adenovirus-SIV Multigene Vaccine Priming and Subunit Boosting, Journal of Virology, vol.78, issue.5, pp.2212-2233, 2004.
DOI : 10.1128/JVI.78.5.2212-2221.2004
URL : http://jvi.asm.org/content/78/5/2212.full.pdf

J. Shiver, T. Fu, L. Chen, D. Casimiro, M. Davies et al., Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity, Nature, vol.415, issue.6869, pp.331-336, 2002.
DOI : 10.1038/415331a

M. Vaccari, A. Boasso, Z. Ma, V. Cecchinato, D. Venzon et al., CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIVmac251 infection, Mucosal Immunology, vol.43, issue.6, pp.497-507, 2008.
DOI : 10.1084/jem.187.9.1373

S. Rerks-ngarm, P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu et al., Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand, New England Journal of Medicine, vol.361, issue.23, pp.2209-2229, 2009.
DOI : 10.1056/NEJMoa0908492

M. Girard, M. Kieny, A. Pinter, F. Barre-sinoussi, N. P. Kolbe et al., Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus., Proceedings of the National Academy of Sciences, vol.88, issue.2, pp.542-548, 1991.
DOI : 10.1073/pnas.88.2.542

M. Belo, M. Yagello, M. Girard, R. Greenlee, A. Deslandres et al., Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees, AIDS, vol.5, issue.2, pp.169-76, 1991.
DOI : 10.1097/00002030-199102000-00006

T. Baba, V. Liska, R. Hofmann-lehmann, J. Vlasak, W. Xu et al., Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection, Nat Med, vol.6, issue.2, pp.200-206, 2000.

J. Mascola, M. Lewis, G. Stiegler, D. Harris, T. Vancott et al., Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies, J Virol, vol.73, issue.5, pp.4009-4027, 1999.

A. Hessell, L. Hangartner, M. Hunter, C. Havenith, F. Beurskens et al., Fc receptor but not complement binding is important in antibody protection against HIV, Nature, vol.75, issue.7158, pp.101-105, 2007.
DOI : 10.1111/j.1600-0684.1999.tb00265.x

R. Hidajat, P. Xiao, Q. Zhou, D. Venzon, L. Summers et al., Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIVmac251 Challenge of Rhesus Macaques, Journal of Virology, vol.83, issue.2, pp.791-801, 2009.
DOI : 10.1128/JVI.01672-08

N. Banks, N. Kinsey, J. Clements, and J. Hildreth, Sustained Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in SIV-Infected Macaques Correlates with Delayed Progression to AIDS, AIDS Research and Human Retroviruses, vol.18, issue.16, pp.1197-205, 2002.
DOI : 10.1089/08892220260387940

S. Ohkawa, K. Xu, L. Wilson, R. Montelaro, L. Martin et al., Analysis of Envelope Glycoprotein-Specific Antibodies from SIV-Infected and gp110-Immunized Monkeys in ACC and ADCC Assays, AIDS Research and Human Retroviruses, vol.11, issue.3, pp.395-403, 1995.
DOI : 10.1089/aid.1995.11.395

A. Chung, E. Rollman, S. Johansson, S. Kent, and I. Stratov, The Utility of ADCC Responses in HIV Infection, Current HIV Research, vol.6, issue.6, pp.515-524, 2008.
DOI : 10.2174/157016208786501472

D. Forthal, G. Landucci, and E. Daar, Antibody from Patients with Acute Human Immunodeficiency Virus (HIV) Infection Inhibits Primary Strains of HIV Type 1 in the Presence of Natural-Killer Effector Cells, Journal of Virology, vol.75, issue.15, pp.6953-61, 2001.
DOI : 10.1128/JVI.75.15.6953-6961.2001

D. Forthal, G. Landucci, K. Cole, M. Marthas, J. Becerra et al., Rhesus Macaque Polyclonal and Monoclonal Antibodies Inhibit Simian Immunodeficiency Virus in the Presence of Human or Autologous Rhesus Effector Cells, Journal of Virology, vol.80, issue.18, pp.9217-9242, 2006.
DOI : 10.1128/JVI.02746-05

T. Yamada, N. Watanabe, T. Nakamura, and A. Iwamoto, Antibody-Dependent Cellular Cytotoxicity via Humoral Immune Epitope of Nef Protein Expressed on Cell Surface, The Journal of Immunology, vol.172, issue.4, pp.2401-2407, 2004.
DOI : 10.4049/jimmunol.172.4.2401

R. Florese, T. Demberg, P. Xiao, L. Kuller, K. Larsen et al., Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines, The Journal of Immunology, vol.182, issue.6, pp.3718-3745, 2009.
DOI : 10.4049/jimmunol.0803115

Y. He, W. Honnen, C. Krachmarov, M. Burkhart, S. Kayman et al., Efficient Isolation of Novel Human Monoclonal Antibodies with Neutralizing Activity Against HIV-1 from Transgenic Mice Expressing Human Ig Loci, The Journal of Immunology, vol.169, issue.1, pp.595-605, 2001.
DOI : 10.4049/jimmunol.169.1.595

M. Wentz, B. Moore, M. Cloyd, S. Berget, and L. Donehower, A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production, J Virol, vol.71, issue.11, pp.8542-51, 1997.

J. Liu, O. Brien, K. Lynch, D. Simmons, N. et al., Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys, Nature, vol.168, issue.7225, pp.87-91, 2009.
DOI : 10.1038/nm1520

R. Florese, K. Van-rompay, K. Aldrich, D. Forthal, G. Landucci et al., Evaluation of Passively Transferred, Nonneutralizing Antibody-Dependent Cellular Cytotoxicity-Mediating IgG in Protection of Neonatal Rhesus Macaques against Oral SIVmac251 Challenge, The Journal of Immunology, vol.177, issue.6, pp.4028-4064, 2006.
DOI : 10.4049/jimmunol.177.6.4028